CCAAT/enhancer binding protein ε is a potential retinoid target gene in acute promyelocytic leukemia treatment
Open accessThe DOI matches its Crossref record; 55 of the 55 references it cites were found in a registry or an index.
Abstract
The CCAAT/enhancer binding protein epsilon (C/EBPepsilon) is a nuclear transcription factor expressed predominantly in myeloid cells and implicated as a potential regulator of myeloid differentiation. We show that it was rapidly induced in the acute promyelocytic leukemia (APL) cell line NB4 during granulocytic differentiation after exposure to retinoic acid (RA). Our data suggest that induction of C/EBPepsilon expression was through the retinoic acid receptor alpha (RARalpha) pathway. Reporter gene studies showed that C/EBPepsilon promoter/enhancer activity increased in a retinoid-dependent fashion via the retinoic acid response element (RARE) present in the promoter region of C/EBPepsilon. The RA-induced expression of C/EBPepsilon markedly increased in U937 myelomonoblasts that were induced to express promyelocytic leukemia/RARalpha (PML/RARalpha), but not in those induced to express promyelocytic leukemia zinc finger/RARalpha (PLZF/RARalpha). In retinoid-resistant APL cell lines, C/EBPepsilon either is not induced or is induced only at very high concentrations of RA (>/=10(-6) M). In addition, forced expression of C/EBPepsilon in the U937 myelomonoblastic leukemia cells mimicked terminal granulocytic differentiation, including morphologic changes, increased CD11b/CD66b expression, and induction of secondary granule protein expression. Our data strongly suggest that C/EBPepsilon is a downstream target gene responsible for RA-induced granulocytic differentiation of APL cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Differentiation induction of haematological malignant cells as well as normal HSC differentiation is mediated by a stochiometric ratio of transcription factors GATA-1 and PU.1 [41], which broadly determine lineage and cooperate with more specific transcription factors such as RAR receptor and CEBP family members [59, 93, 94].”
From PU.1 and partners: regulation of haematopoietic stem cell fate in normal and malignant haematopoiesis (2009) · cites this paper as [94]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Steroid and Thyroid Hormone Receptor Superfamily
Evans, R. M. (1988) · Science · doi:10.1126/science.3283939 · Cited by 7,439 · cited 1×
“Retinoids and their nuclear receptors appear to have multiple functions in the regulation of normal cellular differentiation (1).”
BackgroundUse of all-trans retinoic acid in the treatment of acute promyelocytic leukemia
Huang, M., Ye, Y., Chen, Sr., Chai, Jr., Lu, J., Zhoa, L., Gu, L., & Wang, Z. (1988) · Blood · doi:10.1182/blood.v72.2.567.567 · Cited by 2,445 · cited 1×
“Recently, all-trans retinoic acid (ATRA) has become a standard therapy for the induction of remissions in patients with acute promyelocytic leukemia (APL) (4, 5).”
Background9-cis retinoic acid is a high affinity ligand for the retinoid X receptor
Heyman, R. A., Mangelsdorf, D. J., Dyck, J. A., Stein, R. B., Eichele, G., Evans, R. M., & Thaller, C. (1992) · Cell · doi:10.1016/0092-8674(92)90479-v · Cited by 1,780 · cited 1×
“ATRA binds RAR but does not bind RXR; 9-cis retinoic acid (RA), a naturally occurring RA double-bond isomer, on the other hand, can bind to both RAR/RXR and RXR/RXR receptors (6, 7).”
BackgroundUmesono, K., Murakami, K. K., Thompson, C. C., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90020-y · Cited by 1,716 · cited 2×
“The ligand-receptor complexes transactivate downstream genes that have RAR recognition sequences (8, 9).”
BackgroundMethodLuckow, B., & Schütz, G. (1987) · Nucleic Acids Research · doi:10.1093/nar/15.13.5490 · Cited by 1,701 · cited 6×
“A CAT reporter construct that does not contain a putative RARE site (PRE) was used as a negative control.”
MethodInfluentialKliewer, S. A., Umesono, K., Mangelsdorf, D. J., & Evans, R. M. (1992) · Nature · doi:10.1038/355446a0 · Cited by 1,489 · cited 1×
“The retinoic acid receptor (RAR) forms a heterodimeric complex with the retinoid X receptor (RXR) and has an important function in the transactivation of myeloid-specific genes (2, 3).”
BackgroundKakizuka, A., Miller, W. H., Umesono, K., Warrell, R. P., Frankel, S. R., Murty, V. V. V. S., Dmitrovsky, E., & Evans, R. M. (1991) · Cell · doi:10.1016/0092-8674(91)90112-c · Cited by 1,427
Self-citationde Thé, H., Chomienne, C., Lanotte, M., Degos, L., & Dejean, A. (1990) · Nature · doi:10.1038/347558a0 · Cited by 1,355 · cited 2×
“The ligand-receptor complexes transactivate downstream genes that have RAR recognition sequences (8, 9).”
BackgroundDifferentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)
Warrell, R. P., Frankel, S. R., Miller, W. H., Scheinberg, D. A., Itri, L. M., Hittelman, W. N., Vyas, R., Andreeff, M., Tafuri, A., Jakubowski, A., et al. (1991) · New England Journal of Medicine · doi:10.1056/nejm199105163242002 · Cited by 1,251 · cited 1×
“Recently, all-trans retinoic acid (ATRA) has become a standard therapy for the induction of remissions in patients with acute promyelocytic leukemia (APL) (4, 5).”
BackgroundSelf-citation9-Cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα
Levin, A. A., Sturzenbecker, L. J., Kazmer, S., Bosakowski, T., Huselton, C., Allenby, G., Speck, J., ratzeisen, C., Rosenberger, M., Lovey, A., et al. (1992) · Nature · doi:10.1038/355359a0 · Cited by 1,222 · cited 1×
“ATRA binds RAR but does not bind RXR; 9-cis retinoic acid (RA), a naturally occurring RA double-bond isomer, on the other hand, can bind to both RAR/RXR and RXR/RXR receptors (6, 7).”
Background
Cited by
CCAAT/enhancer-binding proteins: structure, function and regulation
RAMJI, D. P., & FOKA, P. (2002) · Biochemical Journal · doi:10.1042/bj20020508 · Cited by 1,400
Fazi, F., Rosa, A., Fatica, A., Gelmetti, V., De Marchis, M. L., Nervi, C., & Bozzoni, I. (2005) · Cell · doi:10.1016/j.cell.2005.09.023 · Cited by 894
Schug, T. T., Berry, D. C., Shaw, N. S., Travis, S. N., & Noy, N. (2007) · Cell · doi:10.1016/j.cell.2007.02.050 · Cited by 680
“Transcriptional activation by RAR may trigger differentiation (Park et al., 1999; Rochette-Egly and Chambon, 2001), cellcycle arrest (Donato et al.”
BackgroundDisruption of differentiation in human cancer: AML shows the way
Tenen, D. G. (2003) · Nature Reviews Cancer · doi:10.1038/nrc989 · Cited by 612
“For example, the ability of all- trans retinoic acid (ATRA) to induce differentiation of ACUTE PROMYELOCYTIC LEUKAEMIA (APL) cells might be mediated by C/EBP factors — most notably, C/EBPβ and C/EBP&epsi”
BackgroundZhang, P., Iwasaki-Arai, J., Iwasaki, H., Fenyus, M. L., Dayaram, T., Owens, B. M., Shigematsu, H., Levantini, E., Huettner, C. S., Lekstrom-Himes, J. A., et al. (2004) · Immunity · doi:10.1016/j.immuni.2004.11.006 · Cited by 504
Retinoic acid receptors: From molecular mechanisms to cancer therapy
di Masi, A., Leboffe, L., De Marinis, E., Pagano, F., Cicconi, L., Rochette-Egly, C., Lo-Coco, F., Ascenzi, P., & Nervi, C. (2015) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2014.12.003 · Cited by 403
Zhang, X., Lian, Z., Padden, C., Gerstein, M. B., Rozowsky, J., Snyder, M., Gingeras, T. R., Kapranov, P., Weissman, S. M., & Newburger, P. E. (2009) · Blood · doi:10.1182/blood-2008-06-162164 · Cited by 375
Differentiation therapy of leukemia: 3 decades of development.
Nowak, D., Stewart, D., & Koeffler, H. P. (2009) · Blood · doi:10.1182/blood-2009-01-198911 · Cited by 348
Self-citationTranscriptional regulation of granulocyte and monocyte development
Friedman, A. D. (2002) · Oncogene · doi:10.1038/sj.onc.1205324 · Cited by 324
“Indeed, as with C/EBPa, C/EBPb, C/EBPd, or C/EBPe can induce granulocytic di erentiation in myeloblastic cell lines (Park et al., 1999; Nakajima and Ihle, 2001; Wang and Friedman, 2002), and C/EBPa, C/EBPb, or C/EBPd induced monocytic genes in P388 lymphoblasts (Hu et al., 1998).”
BackgroundLiu, T.-X., Zhang, J.-W., Tao, J., Zhang, R.-B., Zhang, Q.-H., Zhao, C.-J., Tong, J.-H., Lanotte, M., Waxman, S., Chen, S.-J., et al. (2000) · Blood · doi:10.1182/blood.v96.4.1496 · Cited by 238
Nuclear receptor PXR, transcriptional circuits and metabolic relevance
Ihunnah, C. A., Jiang, M., & Xie, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.014 · Cited by 225
“RAR forms a heterodimer with RXR and activates the transcription of genes associated with cell differentiation [143] and apoptosis [144], leading to inhibition of cell growth.”
Nagy, L., Szanto, A., Szatmari, I., & Széles, L. (2012) · Physiological Reviews · doi:10.1152/physrev.00004.2011 · Cited by 216
Mueller, B. U., Pabst, T., Fos, J., Petkovic, V., Fey, M. F., Asou, N., Buergi, U., & Tenen, D. G. (2006) · Blood · doi:10.1182/blood-2005-07-3068 · Cited by 207
Between Death and Survival: Retinoic Acid in Regulation of Apoptosis
Noy, N. (2010) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.28.061807.155509 · Cited by 193
The in vivo profile of transcription factors during neutrophil differentiation in human bone marrow
Bjerregaard, M. D., Jurlander, J., Klausen, P., Borregaard, N., & Cowland, J. B. (2003) · Blood · doi:10.1182/blood-2002-03-0835 · Cited by 179
“First of all, it is difficult to reproduce the endogenous milieu and stimuli encountered by the neutrophil precursors in the bone marrow, which is a prerequisite for proper granulocytic differentiation.(6,14) Second, data have often been obtained from asynchronously differentiating cell cultures, which may obscure the…”
BackgroundSchug, T. T., Berry, D. C., Toshkov, I. A., Cheng, L., Nikitin, A. Y., & Noy, N. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0709981105 · Cited by 172
“Activated RAR regulates the expression of multiple target genes, including genes involved in differentiation (6, 7), cellcycle control (8), and apoptosis (9, 10), and it thus often inhibits cell growth.”
BackgroundTranscription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia
Gery, S., Gombart, A. F., Yi, W. S., Koeffler, C., Hofmann, W.-K., & Koeffler, H. P. (2005) · Blood · doi:10.1182/blood-2005-01-0358 · Cited by 168
“To generate stable inducible K562-pMTPer2, K562-pMT, Daudi-pMT , Daudi-pMT, KCL22-pMT , KCL22-pMT,12 U937-pMT , and U937-pMT29 cell lines, K562, Daudi, KCL22, and U937 cells were transfected with pMTPer2, pMT , pMT , or pMT vectors using an electroporation apparatus (Electro Square Porator T820; BTX, San Diego, CA).”
BackgroundSelf-citationThe role of retinoids and retinoic acid receptors in normal hematopoiesis
Collins, S. (2002) · Leukemia · doi:10.1038/sj.leu.2402718 · Cited by 167
C/EBP : a major PML-RARA-responsive gene in retinoic acid-induced differentiation of APL cells
Duprez, E. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg556 · Cited by 165
Kiss, M., Czimmerer, Z., & Nagy, L. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.05.044 · Cited by 161
Transcriptional regulation in acute promyelocytic leukemia
Lin, R. J., Sternsdorf, T., Tini, M., & Evans, R. M. (2001) · Oncogene · doi:10.1038/sj.onc.1204853 · Cited by 182
“…as C/EBPe, HoxA1 and p21, are known to play important roles in regulating myeloid cell proliferation and di erentiation (Casini and Pelicci, 1999; Park et al., 1999; Lin et al., unpublished results), it is conceivable that inhibition of their expression by X-RARa fusion proteins will lead to di…”
BackgroundGombart, A. F., Kwok, S. H., Anderson, K. L., Yamaguchi, Y., Torbett, B. E., & Koeffler, H. P. (2003) · Blood · doi:10.1182/blood-2002-04-1039 · Cited by 151
Self-citationPositive and negative regulation of granulopoiesis by endogenous RARα
Kastner, P., Lawrence, H. J., Waltzinger, C., Ghyselinck, N. B., Chambon, P., & Chan, S. (2001) · Blood · doi:10.1182/blood.v97.5.1314 · Cited by 133
Gombart, A. F., Shiohara, M., Kwok, S. H., Agematsu, K., Komiyama, A., & Koeffler, H. P. (2001) · Blood · doi:10.1182/blood.v97.9.2561 · Cited by 132
Self-citationThe Role of C/EBPε in the Terminal Stages of Granulocyte Differentiation
Lekstrom‐Himes, J. A. (2001) · STEM CELLS · doi:10.1634/stemcells.19-2-125 · Cited by 127
Donato, L. J., & Noy, N. (2005) · Cancer Research · doi:10.1158/0008-5472.can-05-1177 · Cited by 123
Rosmarin, A. G., Yang, Z., & Resendes, K. K. (2005) · Experimental Hematology · doi:10.1016/j.exphem.2004.08.015 · Cited by 121
“It should be noted, however, that other C/EBP factors also induce granulocytic differentiation in myeloblastic cell lines [119–122].”
BackgroundIkezoe, T., Chen, S. S., Heber, D., Taguchi, H., & Koeffler, H. P. (2001) · The Prostate · doi:10.1002/pros.10024 · Cited by 120
Self-citationThe C/EBPδ tumor suppressor is silenced by hypermethylation in acute myeloid leukemia
Agrawal, S., Hofmann, W.-K., Tidow, N., Ehrich, M., Boom, D. V. D., Koschmieder, S., Berdel, W. E., Serve, H., & Müller-Tidow, C. (2007) · Blood · doi:10.1182/blood-2006-08-040147 · Cited by 119
Kitareewan, S., Pitha-Rowe, I., Sekula, D., Lowrey, C. H., Nemeth, M. J., Golub, T. R., Freemantle, S. J., & Dmitrovsky, E. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.052011299 · Cited by 117
Donato, L. J., Suh, J. H., & Noy, N. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-0989 · Cited by 118
Regulation of human neutrophil granule protein expression
Borregaard, N., Theilgaard-Mönch, K., Sørensen, O. E., & Cowland, J. B. (2001) · Current Opinion in Hematology · doi:10.1097/00062752-200101000-00005 · Cited by 103
CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia
Truong, B.-T. H. (2003) · Blood · doi:10.1182/blood-2002-05-1374 · Cited by 103
“16 This leukemia is now defined by the presence of a t(15;17)(q22;q12) chromosomal translocation, creating a PML-RARA fusion gene (or rare variants that also result in fusions to RARA).”
BackgroundSelf-citationGombart, A. F., & Koeffler, H. P. (2002) · Current Opinion in Hematology · doi:10.1097/00062752-200201000-00007 · Cited by 107
Self-citationC/EBPα: A tumour suppressor in multiple tissues?
Schuster, M. B., & Porse, B. T. (2006) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2006.02.003 · Cited by 99
Transcription factors that regulate growth and differentiation of myeloid cells.
Nagamura-Inoue, T., Tamura, T., & Ozato, K. (2001) · International Reviews of Immunology · doi:10.3109/08830180109056724 · Cited by 94
C/EBPε mediates nicotinamide-enhanced clearance of Staphylococcus aureus in mice
Kyme, P., Thoennissen, N. H., Tseng, C. W., Thoennissen, G. B., Wolf, A. J., Shimada, K., Krug, U. O., Lee, K., Müller-Tidow, C., Berdel, W. E., et al. (2012) · Journal of Clinical Investigation · doi:10.1172/jci62070 · Cited by 86
Self-citationWang, Q.-F., & Friedman, A. D. (2002) · Blood · doi:10.1182/blood.v99.8.2776 · Cited by 89
Common themes in the pathogenesis of acute myeloid leukemia
Alcalay, M., Orleth, A., Sebastiani, C., Meani, N., Chiaradonna, F., Casciari, C., Sciurpi, M. T., Gelmetti, V., Riganelli, D., Minucci, S., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204642 · Cited by 107
“Forced expression of C/ EBPe in U937 cells mimics terminal granulocytic di erentiation, including morphologic changes, increased CD11b/CD66b expression, and induction of secondary granule protein expression (Park et al., 1999).”
BackgroundLee, K.-H., Chang, M., Ahn, J., Yu, D., Jung, S. S., Choi, J.-H., Noh, Y., Lee, Y., & Ahn, M.-J. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)02043-0 · Cited by 96
Borutinskaite, V. V., Vitkevičienė, A., Gudelytė, G., & Navakauskienė, R. (2017) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428194.2017.1339881 · Cited by 87
“APL is a subtype of AML featuring aberrant fusion protein PML-RARa, which can inhibit C/EBPa and C/EBPE activities [23,24].”
BackgroundFunction of RARα during the maturation of neutrophils
Kastner, P., & Chan, S. H. (2001) · Oncogene · doi:10.1038/sj.onc.1204757 · Cited by 94
“C/EBPe transcription is rapidly induced by retinoic acid in the absence of protein synthesis in HL60 and NB4 cells (Chih et al., 1997; Liu et al., 2000), and a functional RARE has been identi®ed in the C/EBPe promoter (Park et al., 1999).”
BackgroundPark, D. J., Vuong, P. T., de Vos, S., Douer, D., & Koeffler, H. P. (2003) · Blood · doi:10.1182/blood-2003-02-0412 · Cited by 84
Self-citationRibeiro, O. G., Maria, D. A., Adriouch, S., Pechberty, S., Cabrera, W. H. K., Morisset, J., Ibañez, O. M., & Séman, M. (2003) · Journal of Leukocyte Biology · doi:10.1189/jlb.0103039 · Cited by 84
“At last, the C/EBPε promoter contains a retinoic acid responding element (RARE) element, suggesting that C/EBPε might be one of the RAR targets [35] providing a rational mechanism for ATRA-mediated granulopoiesis regulation [36].”
BackgroundInduction of granulocytic differentiation by 2 pathways
Zhang, P., Nelson, E., Radomska, H. S., Iwasaki-Arai, J., Akashi, K., Friedman, A. D., & Tenen, D. G. (2002) · Blood · doi:10.1182/blood.v99.12.4406 · Cited by 78
Nakajima, H. (2001) · Blood · doi:10.1182/blood.v98.4.897 · Cited by 76
Inhibition of Aldehyde Dehydrogenase Expands Hematopoietic Stem Cells with Radioprotective Capacity
Muramoto, G. G., Russell, J. L., Safi, R., Salter, A. B., Himburg, H. A., Daher, P., Meadows, S. K., Doan, P. L., Storms, R. W., Chao, N. J. A., et al. (2010) · Stem Cells · doi:10.1002/stem.299 · Cited by 76
Gupta, P., Gurudutta, G. U., Saluja, D., & Tripathi, R. P. (2009) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2009.00757.x · Cited by 74
“1 [41], which broadly determine lineage and cooperate with more specific transcription factors such as RAR receptor and CEBP family members [59, 93, 94].”
BackgroundRetinoid target genes in acute promyelocytic leukemia
Pitha, I., Petty, W. J., Kitareewan, S., & Dmitrovsky, E. (2003) · Leukemia · doi:10.1038/sj.leu.2403065 · Cited by 76
Heuzé, M. L., Guibal, F. C., Banks, C. A., Conaway, J. W., Conaway, R. C., Cayre, Y. E., Benecke, A., & Lutz, P. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413040200 · Cited by 73
Retinoic acid receptors, hematopoiesis and leukemogenesis
Collins, S. J. (2008) · Current Opinion in Hematology · doi:10.1097/moh.0b013e3283007edf · Cited by 71
Curcumin restores sensitivity to retinoic acid in triple negative breast cancer cells
Thulasiraman, P., McAndrews, D. J., & Mohiuddin, I. Q. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-724 · Cited by 73
“The ligandreceptor complex acts as a transcription factor which binds to a specific DNA sequence element found on the promoter regions of target genes called retinoic acid response element (RARE) [32-35].”
BackgroundResultIkezoe, T., Tanosaki, S., Krug, U. O., Liu, B.-R., Cohen, P., Taguchi, H., & Koeffler, H. P. (2004) · Blood · doi:10.1182/blood-2003-07-2203 · Cited by 69
Self-citationSynergy between all-trans retinoic acid and tumor necrosis factor pathways in acute leukemia cells
Witcher, M., Ross, D. T., Rousseau, C., deLuca, L. S., & Miller, W. H. (2003) · Blood · doi:10.1182/blood-2002-09-2725 · Cited by 76
Self-citationRusiniak, M. E., Yu, M., Ross, D. T., Tolhurst, E. C., & Slack, J. L. (2000) · PubMed · Cited by 66
C/EBPϵ interacts with retinoblastoma and E2F1 during granulopoiesis
Gery, S., Gombart, A. F., Fung, Y. K., & Koeffler, H. P. (2003) · Blood · doi:10.1182/blood-2003-01-0159 · Cited by 71
Self-citationC/EBPδ expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation
Gery, S., Tanosaki, S., Hofmann, W., Koppel, A. B., & Koeffler, H. P. (2005) · Oncogene · doi:10.1038/sj.onc.1208393 · Cited by 69
“…of either C/ EBPa, C/EBPb, C/EBPd or C/EBPe in hematopoietic cells is sufficient for granulocytic differentiation in myeloid cell lines (Radomska et al., 1998; Park et al., 1999; Wang and Friedman 2002), indicating that C/EBP family members can compensate for the lack of a specific subtype.”
BackgroundSelf-citationGianni’, M., Kalaç, Y., Ponzanelli, I., Rambaldi, A., Terao, M., & Garattini, E. (2001) · Blood · doi:10.1182/blood.v97.10.3234 · Cited by 64
Khanna‐Gupta, A., Zibello, T., Sun, H., Gaines, P. C. W., & Berliner, N. (2003) · Blood · doi:10.1182/blood-2002-09-2767 · Cited by 64
C/EBPɛ mediates myeloid differentiation and is regulated by the CCAAT displacement protein (CDP/cut)
Khanna-Gupta, A., Zibello, T., Sun, H., Lekstrom-Himes, J., & Berliner, N. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.141229598 · Cited by 59
Ikezoe, T., Gery, S., Yin, D. X., O’Kelly, J., Binderup, L., Lemp, N. A., Taguchi, H., & Koeffler, H. P. (2005) · Cancer Research · doi:10.1158/0008-5472.can-03-3619 · Cited by 62
“For example, C/EBPq plays an important role in the differentiation of hematopoietic progenitor cells toward the granulocytic lineage; indeed, forced expression of C/EBPq in U937 leukemic myeloblasts can induce these cells to differentiate towards granulocytes ( 16 ).”
BackgroundSelf-citationIkezoe, T., Daar, E. S., Hisatake, J., Taguchi, H., & Koeffler, H. P. (2000) · Blood · doi:10.1182/blood.v96.10.3553 · Cited by 56
Self-citationMolecular pathogenesis of acute promyelocytic leukaemia and APL variants
Sirulnik, A., Melnick, A., Zelent, A., & Licht, J. D. (2003) · Best Practice & Research Clinical Haematology · doi:10.1016/s1521-6926(03)00062-8 · Cited by 54
Pendino, F., Nguyen, E., Jonassen, I., Dysvik, B., Azouz, A., Lanotte, M., Ségal-Bendirdjian, E., & Lillehaug, J. R. (2009) · Blood · doi:10.1182/blood-2008-07-170035 · Cited by 51
ATRA‐regulated Asb‐2 gene induced in differentiation of HL‐60 leukemia cells
Kohroki, J., Fujita, S., Itoh, N., Yamada, Y., Imai, H., Yumoto, N., Nakanishi, T., & Tanaka, K. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02829-0 · Cited by 57
Differential Retinoic Acid Signaling in Tumors of Long- and Short-term Glioblastoma Survivors
Barbus, S., Tews, B., Karra, D., Hahn, M., Radlwimmer, B., Delhomme, N., Hartmann, C. J., Felsberg, J., Krex, D., Schackert, G., et al. (2011) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djr036 · Cited by 58
“Activation of RARs typically leads to differentiation (13), cell cycle arrest (14), apoptosis (15,16), and consequently to reduced cell proliferation (10).”
BackgroundSi, J., Mueller, L., & Collins, S. J. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30779 · Cited by 45
“org Volume 117 Number 5 May 2007 HL60 (Figure 6A), and this is mediated through a specific RARE located 190 bp upstream of the C/EBPε translation start site (35).”
Differentiation Therapy of Acute Myeloid Leukemia
Gocek, E., & Marcinkowska, E. (2011) · Cancers · doi:10.3390/cancers3022402 · Cited by 56
“1) [73,84], chromatin-regulating factors [63,85], cell cycle regulators [86,87], as well as protein synthesis inhibitors [88].”
BackgroundTranscriptional mechanisms regulating myeloid-specific genes
Skalnik, D. G. (2002) · Gene · doi:10.1016/s0378-1119(02)00387-6 · Cited by 58
Retinoid receptor signaling and autophagy in acute promyelocytic leukemia
Orfali, N., McKenna, S. L., Cahill, M. R., Gudas, L. J., & Mongan, N. P. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.03.018 · Cited by 49
Savickienė, J., Treigytė, G., Valiulienė, G., Stirblytė, I., & Navakauskienė, R. (2014) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000122 · Cited by 47
Acetylation of C/EBPε is a prerequisite for terminal neutrophil differentiation
Bartels, M., Govers, A. M. A. P., Fleskens, V., Lourenço, A. R., Pals, C. E. G. M., Vervoort, S. J., van Gent, R., Brenkman, A. B., Bierings, M., Ackerman, S. J., et al. (2015) · Blood · doi:10.1182/blood-2013-12-543850 · Cited by 51
“NB4 cells were pretreated with retinoic acid for 4 days to increase C/EBPe expression.(39) Protein lysates were prepared, followed by acetyl lysine-immunoprecipitation and immunoblotting, using a C/EBPe antibody.”
Bush, T. S., St. Coeur, M., Resendes, K. K., & Rosmarin, A. G. (2003) · Blood · doi:10.1182/blood.v101.1.311 · Cited by 47
Yoshida, H., Ichikawa, H., Tagata, Y., Katsumoto, T., Ohnishi, K., Akao, Y., Naoe, T., Pandolfi, P. P., & Kitabayashi, I. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.02422-06 · Cited by 45
“Although the P promoter contains RARE, and C/EBPε is upregulated by a pharmacological dose of RA, at least in vitro (23), RA treatment does not affect the DNase I hypersensitivity of P (14).”
BackgroundResultNishioka, C., Ikezoe, T., Yang, J., Gery, S., Koeffler, H. P., & Yokoyama, A. (2009) · International Journal of Cancer · doi:10.1002/ijc.24472 · Cited by 43
Self-citationZhuang, D., Qiu, Y., Kogan, S. C., & Dong, F. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m510924200 · Cited by 48
Transcriptional Regulation of Myelopoiesis
Friedman, A. D. (2002) · International Journal of Hematology · doi:10.1007/bf02982108 · Cited by 51
Current issues in the management of acute promyelocytic leukemia
Slack, J. L., & Rusiniak, M. E. (2000) · Annals of Hematology · doi:10.1007/s002770050585 · Cited by 47
“C/EBP epsilon and p21 Waf1/Cip1 [ 18 , 19], have also”
Nakajima, H., Watanabe, N., Shibata, F., Kitamura, T., Ikeda, Y., & Handa, M. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600575200 · Cited by 51
The PML-RARα Fusion Protein and Targeted Therapy for Acute Promyelocytic Leukemia
Jing, Y. (2003) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/10428190310001609933 · Cited by 52
“transactivate gene expression (although only at pharmacological concentrations of ATRA) [58].”
BackgroundWang, Y., Jin, W., Jia, X., Luo, R., Tan, Y., Zhu, X., Yang, X., Wang, X., & Wang, K. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.388 · Cited by 42
Sakamoto, K., Imamura, T., Yano, M., Yoshida, H., Fujiki, A., Hirashima, Y., & Hosoi, H. (2014) · Blood Cancer Journal · doi:10.1038/bcj.2014.25 · Cited by 45
Sanchez, P. V., Glantz, S. T., Scotland, S., Kasner, M. T., & Carroll, M. P. (2013) · Leukemia · doi:10.1038/leu.2013.202 · Cited by 41
Ying, M., Zhou, X., Zhong, L., Lin, N., Jing, H., Luo, P., Yang, X., Song, H., Yang, B., & He, Q. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0433 · Cited by 40
Lennartsson, A., Pieters, K., Vidovic, K., & Gullberg, U. (2004) · Journal of Leukocyte Biology · doi:10.1189/jlb.0304159 · Cited by 40
“The mechanisms for ATRA-induced differentiation of human myeloid cells include an increase in the transcription factor C/enhancer-binding protein (EBP)e, which contains ATRA-response elements in its promoter [ 33 ].”
BackgroundWalkley, C. R., Purton, L. E., Snelling, H. J., Yuan, Y.-D., Nakajima, H., Chambon, P., Chandraratna, R. A. S., & McArthur, G. A. (2003) · Blood · doi:10.1182/blood-2003-07-2391 · Cited by 42
Chumakov, A. M., Kubota, T., Walter, S., & Koeffler, H. P. (2004) · Oncogene · doi:10.1038/sj.onc.1207126 · Cited by 40
“C/EBP-e is strongly upregulated following treatment with 9-cis retinoic acid (RA) in NB4 cells (Chumakov et al., 1997; Park et al., 1999).”
BackgroundSelf-citationCheng, X., & Kao, H. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.062109 · Cited by 42
KUO, H., KUO, W., Lee, Y. S., Wang, C. C., & Tseng, T. (2006) · Toxicology and Applied Pharmacology · doi:10.1016/j.taap.2006.04.007 · Cited by 37
Gery, S., Park, D. J., Vuong, P. T., Chih, D. Y., Lemp, N. A., & Koeffler, H. P. (2004) · Blood · doi:10.1182/blood-2003-10-3688 · Cited by 39
Self-citationPML a target of translocations in APL is a regulator of cellular senescence
Ferbeyre, G. (2002) · Leukemia · doi:10.1038/sj.leu.2402722 · Cited by 38
Zhou, N., Yao, Y., Ye, H., Zhu, W. P., Chen, L., & Mao, Y. Q. (2015) · International Journal of Cancer · doi:10.1002/ijc.29935 · Cited by 34
Jing, Y., Xia, L., & Waxman, S. (2002) · Blood · doi:10.1182/blood.v100.3.1008 · Cited by 37
RTP801 is a novel retinoic acid–responsive gene associated with myeloid differentiation
Gery, S., Park, D. J., Vuong, P. T., Virk, R. K., Müller, C. I., Hofmann, W., & Koeffler, H. P. (2007) · Experimental Hematology · doi:10.1016/j.exphem.2007.01.049 · Cited by 34
“NIH 3T3 cells were cotransfected with a RTP801 promoter reporter construct [pGL3-RTP801, generous gift from Y. Chen, Indiana University, Indianapolis, IN (19), 0.6 μg], along with either C/EBPε expression vector or empty vector (0.6 μg).”
BackgroundInfluentialSelf-citationRivera-Gonzalez, G. C., Droop, A., Rippon, H. J., Tiemann, K., Pellacani, D., Georgopoulos, L. J., & Maitland, N. J. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks143 · Cited by 35
Gombart, A. F., Grewal, J., & Koeffler, H. P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0806516 · Cited by 35
“The 32- and 30-kDa isoforms activate transcription of important neutrophil and eosinophil granule genes and promote granulocytic differentiation [23, 24 ], and the 27-kDa form represses eosinophil major basic protein gene expression [25].”
Self-citationMiranda, M. B., Redner, R. L., & Johnson, D. E. (2007) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0514 · Cited by 36
Pisano, C., Kollár, P., Gianni’, M., Kalaç, Y., Giordano, V., Ferrara, F. F., Tancredi, R. J., Devoto, A., Rinaldi, A., Rambaldi, A., et al. (2002) · Blood · doi:10.1182/blood-2002-03-0720 · Cited by 31
“Vehicle — 0/7 0 (39-46) 43 — ATRA 5 0/7 0 (42-63) 45 5 ST1346 15 0/7 0 (34-48) 39 — ST1346 30 0/6 0 ( 36-64 ) 40 — ATRA ST1346 5 15 0/7 0 (42-65) 49 14 ATRA ST1346 5 30 0/7 0 (46-70) 60*,† 40”
Noack, K., Mahendrarajah, N., Hennig, D., Schmidt, L., Grebien, F., Hildebrand, D., Christmann, M., Kaina, B., Sellmer, A., Mahboobi, S., et al. (2016) · Archives of Toxicology · doi:10.1007/s00204-016-1878-5 · Cited by 33
“GAPDH, served as reference gene. b SubG1 phase of NB4 cells treated for 48 h with 1 µM ATRA and/or 100– 400 nM ABT-737 for 24 h. DNA fragmentation was determined by flow cytometry after PI staining; n = 3. c NB4 cells were stimulated for indicated times with 1 µM ATRA or with 100 ng/ml INF-γ.”
MethodBerry (2007) · doi:10.1155/2007/73256 · Cited by 28
“In this fashion, RA also displays distinct anticarcinogenic activities mediated by RARinduced upregulation of genes involved in cell cycle arrest [38], differentiation [39, 40], and apoptosis [41–43].”
Background
Metadata
- Authors
- Park, D. J., Chumakov, A. M., Vuong, P. T., Chih, D. Y., Gombart, A. F., Miller, W. H., & Koeffler, H. P.
- Affiliations
- Cedars-Sinai Medical Center (US)
- Lady Davis Institute for Medical Research (CA)
- Corresponding author
- Park, Dorothy J.
- Venue
- Journal of Clinical Investigation
- Published
- 1999-05-15
- Volume
- 103
- Issue
- 10
- Pages
- 1399-1408
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC408448
- OpenAlex
- W2042117566
- Cited by
- 187
- References
- 55
- Citations by year
- 2025: 3 · 2024: 5 · 2023: 1 · 2022: 1 · 2021: 3 · 2020: 2 · 2019: 7 · 2018: 1 · 2017: 7 · 2016: 7 · 2015: 3 · 2014: 11 · 2013: 6 · 2012: 6
- FWCI
- 5.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Cedars-Sinai Medical Center
- National Institutes of Health
- University of California, Los Angeles
- Jonsson Comprehensive Cancer Center
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Retinoids in leukemia and cellular processes
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Peroxisome Proliferator-Activated Receptors
- Keywords
- acute promyelocytic leukemia, retinoic acid, retinoic acid receptor alpha, retinoic acid response element, granulocytic differentiation, PML-RARα, PLZF-RARα, retinoid resistance, transcriptional regulation, myeloid differentiation, NB4 cells, U937 cells
- MeSH terms
- Retinoic Acid Receptor alpha, Cell Differentiation, DNA-Binding Proteins, Drug Resistance, Enhancer Elements, Genetic, Humans, Nuclear Proteins, Promoter Regions, Genetic, Retinoids, Tretinoin, Tumor Cells, Cultured, Leukemia, Promyelocytic, Acute, Gene Expression, Genes, Reporter, Receptors, Retinoic Acid, U937 Cells, CCAAT-Enhancer-Binding Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.